Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conclusions of the symposium

P Gambetti1, E Lugaresi

  • 1Division of Neuropathology, Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.

Brain Pathology (Zurich, Switzerland)
|July 21, 1998
PubMed
Summary

Fatal familial insomnia (FFI) is a distinct inherited prion disease, characterized by a specific genetic mutation and unique brain changes. Disease duration varies based on genetic factors at codon 129.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoactive-hypoalert behavior ("psychic akinesia") in intracranial hypotension syndrome.

Neurology·2008
Same author

Fatal insomnia and agrypnia excitata: sleep and the limbic system.

Revue neurologique·2008
Same author

What are the causes of excessive daytime sleepiness in patients with sleep-disordered breathing?

The European respiratory journal·2008
Same author

Sporadic fatal insomnia in a fatal familial insomnia pedigree.

Neurology·2008
Same author

Catathrenia (nocturnal groaning): an abnormal respiratory pattern during sleep.

European journal of neurology·2007
Same author

Sleep-related breathing disorders and headache.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2006

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • Fatal familial insomnia (FFI) is a rare, inherited prion disease.
  • FFI presents with distinct genetic and pathological features.
  • It is considered the third most common inherited prion disease.

Purpose of the Study:

  • To confirm the distinct genotypic and phenotypic characteristics of FFI.
  • To analyze the genetic basis, histopathology, and clinical manifestations of FFI.
  • To differentiate FFI from similar conditions.

Main Methods:

  • Genotyping for D178N mutation and codon 129 polymorphism.
  • Immunoblotting to analyze PrPres molecular mass and glycosylation.
  • Histopathological examination of brain tissue.
  • Polysomnography for sleep disorder assessment.
  • Clinical evaluation of autonomic, endocrine, and cognitive functions.

Main Results:

  • All FFI cases showed the D178N mutation with methionine at codon 129.
  • PrPres immunoblotting revealed a ~19kDa core protein with underrepresented unglycosylated form.
  • Histopathology showed thalamic and inferior olivary atrophy with cerebral spongiosis.
  • Homozygosity at codon 129 correlated with a shorter disease duration.
  • FFI sleep disorder characterized by lack of spindle activity and disrupted wake-sleep cycle.

Conclusions:

  • FFI is a distinct inherited prion disease with a specific genetic signature (D178N/129M).
  • Histopathological and immunoblot findings are characteristic of FFI.
  • Genetic variations at codon 129 influence disease duration.
  • Sporadic forms require demonstration of specific clinical and pathological abnormalities.

Related Experiment Videos